Ignite Creation Date:
2024-05-06 @ 3:20 PM
Last Modification Date:
2024-10-26 @ 1:47 PM
Study NCT ID:
NCT04601766
Status:
COMPLETED
Last Update Posted:
2021-06-30
First Post:
2020-10-20
Brief Title:
A Phase I Two-phase Crossover Study to Evaluate the Safety Tolerability and Pharmacokinetics of APL-1501 ER Tablets
Sponsor:
Asieris Pharmaceuticals AUS Pty Ltd
Organization:
Jiangsu Yahong Meditech Co Ltd aka Asieris
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Bladder Cancer |
Keywords: